Rhuematoid Arthritis Flashcards
DAS assessment in management
A score called the Disease Activity Score (DAS) to support a targeted combination treatment to escalate therapy as needed to control disease activity:
- DAS scores below 2.6 indicate remission (i.e. free from symptoms)
- DAS scores between 2.6 to 3.2 indicate low disease
- whereas scores between 3.2 to 5.1 indicate moderate disease levels.
- DAS scores above 5.1 indicate high disease levels: start biologics
A change in DAS scare of less than 0.7 means no response
Genetic Associations of Rheumatoid Arthritis
HLA DR4 (a gene often present in RF positive patients) - most common
HLA DR1 (a gene occasionally present in RA patients)
Diagnosis
Bloods:
- CRP, ESR
- Rheumatoid Factor
- Anti-CCP
X- ray:
- Loss of joint space
- Erosions (periarticular)
- Soft tissue swelling
- Subluxation
- Periarticular osteopaenia
Clinical Features
Hand features
- pain and stiffness in the small joints of the hands and feet, : wrist, ankle, MCP and PIP joints in the hands
- Z shaped deformity to the thumb
- Swan neck deformity (hyperextended PIP with flexed DIP)
- Boutonnieres deformity (hyperextended DIP with flexed PIP)
- Ulnar deviation of the fingers at the knuckle (MCP joints)
Ocular manifestations
Most common
keratoconjunctivitis sicca (most common) episcleritis (erythema) scleritis (erythema and pain) corneal ulceration keratitis
What can happen in the neck in RA
Atlantoaxial subluxation occurs in the cervical spine.
The axis (C2) and the odontoid peg shift within the atlas (C1).
This is caused by local synovitis and damage to the ligaments and bursa around the odontoid peg of the axis and the atlas.
Subluxation can cause spinal cord compression and is an emergency.
This is particularly important if the patient is having a general anaesthetic and requiring intubation.
MRI scans can visualise changes in these areas as part of pre-operative assessment.
Management
NICE guidelines
Monitoring progress
Flares
NICE: DMARD monotherapy +/- a short-course of bridging prednisolone.
DMARDs
- methotrexate is the most widely used DMARD
- sulfasalazine (safer in pregnancy)
- leflunomide
- hydroxychloroquine (safer in pregnancy)
Biologics
Infliximab - monoclonal antibody against TNF
Etanercept - anti TNF
Rituximab - anti CD20
Monitoring response to treatment: CRP and disease activity (using a composite score such as DAS28) to assess response to treatment
FLARES:
flares of RA are often managed with corticosteroids - oral or intramuscular
Notable side effects of DMARDs and biologics
All have a risk of hepatoxicity
- Methotrexate: pulmonary fibrosis and risk of myelosuppression
- Leflunomide: Hypertension and peripheral neuropathy
- Sulfasalazine: Male infertility (reduces sperm count)
- Hydroxychloroquine: Nightmares and reduced visual acuity
- Anti-TNF medications: Reactivation of TB or hepatitis B
- Rituximab: Night sweats and thrombocytopenia
Complications
Felty’s Syndrome: Rheumatoid arthritis, neutropaenia, splenomegaly
Amyloidosis